Inventors:
David M. Berman - Princeton NJ, US
Scott D. Chasalow - Pennington NJ, US
International Classification:
A61K 49/00, A61P 43/00
Abstract:
The invention described herein relates to diagnostic and therapeutic methods and compositions useful for predicting the likelihood a patient will have favorable response to the administration of a pharmaceutically acceptable amount of an activator of the immune system (e.g, T-cells).